Liu Jianping, Xie Mingfeng, Duan Xunhong, Liu Fengen, Luo Pan, Liu Qian
Suzhou Medical College of Soochow University Suzhou, Jiangsu, China.
Jiangxi Provincial Clinical Research Center for Vascular Anomalies, The First Affiliated Hospital of Gannan Medical University Ganzhou, Jiangxi, China.
Am J Transl Res. 2023 Aug 15;15(8):5035-5046. eCollection 2023.
This study aimed to analyze the mutation site in a family diagnosed with venous dysplasia to identify possible pathogenic genes.
A 15-year-old female presented with lower extremity venous tortuosity aggravated by ulceration. Only the young sister exhibited similar symptoms within the immediate family of the proband. Whole genome sequencing (WGS) was used to evaluate the mutation sites and chromosome copy number variations (CNV) within the family. The possible pathogenic genes located in the region with CNVs were identified, and the expression of the possible pathogenic genes was verified via quantitative polymerase chain reaction (Q-PCR) and western blotting (WB) analysis. In-vitro models were used to verify the role of possible pathogenic genes linked with the development of venous dysplasia.
The high-resolution karyotype analysis of the chromosomes found no abnormalities. The results of the WGS indicated that the proband and her sister shared the CNV events, including a microdeletion on chromosomes X: 13580000-1358555000 and microduplications of chromosome X: 136055000-136290000, chromosome X: 136475000-13671000. The results of the Q-PCR and WB showed that FHL1 was highly expressed in the proband and her sister, indicating that mutations of the FHL1 may have an important role in the development of vein malformations. The results of the in vitro experiments showed that FHL1 overexpression could inhibit venous development.
The CNV in the Xq26 region (136054501-136288300) was found to be linked with the development of venous malformations in this family. However, further studies are required to evaluate the genetic mechanisms involved in the development of venous malformations.
本研究旨在分析一个被诊断为静脉发育异常的家族中的突变位点,以确定可能的致病基因。
一名15岁女性因下肢静脉迂曲并伴有溃疡而就诊。在先证者的直系亲属中,只有其妹妹表现出类似症状。采用全基因组测序(WGS)评估该家族中的突变位点和染色体拷贝数变异(CNV)。鉴定位于CNV区域内的可能致病基因,并通过定量聚合酶链反应(Q-PCR)和蛋白质免疫印迹(WB)分析验证可能致病基因的表达。利用体外模型验证与静脉发育异常相关的可能致病基因的作用。
染色体的高分辨率核型分析未发现异常。WGS结果表明,先证者及其妹妹存在共同的CNV事件,包括X染色体上13580000 - 1358555000的微缺失以及X染色体上136055000 - 136290000、X染色体上136475000 - 13671000的微重复。Q-PCR和WB结果显示,FHL1在先证者及其妹妹中高表达,表明FHL1突变可能在静脉畸形的发生发展中起重要作用。体外实验结果表明,FHL1过表达可抑制静脉发育。
发现该家族中Xq26区域(136054501 - 136288300)的CNV与静脉畸形的发生发展有关。然而,需要进一步研究来评估静脉畸形发生发展所涉及的遗传机制。